Searchable abstracts of presentations at key conferences in endocrinology

ea0098o4 | Other | NANETS2023

Baseline grade discordance in patients with pancreatic neuroendocrine tumors (PanNETs)

Moon Farhana , Wang Stephanie , Paciorek Alan , Khuong Le Bryan , Nakakura Eric , Zhang Li , Joseph Nancy M. , Bergsland Emily

Background: Pancreatic neuroendocrine tumors (panNETs) are heterogeneous, with grade (G) defined by Ki67 proliferation index (<3% G1, 3-20% G2, and >20% G3) or mitotic rate. Previous studies suggest that baseline Ki67 index may be confounded by biopsy site (primary or metastasis), biopsy technique and primary tumor size. Ki67 differences leading to grade discordance in PanNETs at baseline is relatively understudied. Our study aims to evaluate grade discordance in synch...

ea0022p781 | Thyroid | ECE2010

Coagulation disorders in hypothyroidism: effects of thyroid hormones deficiency and/or of TSH?

Yango John , Alexopoulou Orsalia , Eeckoudt Stephane , Hermans Cedric , Daumerie Chantal

Various haemostatic abnormalities have been associated with thyroid dysfunction, especially with hypothyroidism. The underlying mechanisms are not well established.The aim of the study was to evaluate the primary and secondary haemostasis in patients with severe hypothyroidism, to assess the role of thyroid hormone deficiency and to determine whether increased serum TSH level despite normal free thyroid hormone concentrations could influence the coagulat...

ea0078oc4.8 | Oral Communications 4 | BSPED2021

Destination outcome of 1151 gender variant young people presenting to paediatric endocrinology clinics in England and Wales since 2008.

Butler Gary , Adu-Gyamfi Kirpal , Clarkson Kerry , Kleczewski Sara , Roberts Alice , Ward Stephanie , Alvi Sabah , Amin Nadia , Carruthers Paul , Dover Stacey , Eastman Joanna , Mushtaq Talat

Introduction: The destination of young people referred from the NHS Gender Identity Development Service (GIDS) to the two paediatric endocrine centres covering England and Wales has not been analysed previously.Methods: 1151 young people identifying as gender variant were referred from GIDS for an endocrine opinion: 827 patients to University College London Hospital (UCLH) from 2008; 324 to Leeds Children’s Hospital (LCH) from 2013. Outcomes were no...

ea0054is1 | (1) | NuclearReceptors2018

MicroRNA regulation of androgen signalling

Fletcher Claire E , Sita-Lumsden Ailsa , Dart Alwyn , Shibakawa Akifumi , Sulpice Eric , Combe Stephanie , Leach Damien A , de Bono Johann , Lupold SE , McGuire SE , Gidrol Xavier , Bevan Charlotte L

Androgens initially drive prostate tumour growth. Although in advanced disease there is no longer dependence on circulating androgens, the androgen receptor (AR) remains a key driver of this lethal stage thus new ways to inhibit its activity are required. MicroRNAs play vital roles in prostate cancer (PCa) development, progression and metastasis. Previous studies have examined microRNAs dysregulated in PCa, and also identified androgen-regulated microRNAs. We approached microR...

ea0079020 | Abstracts | BES2021

HLA-DR4/DR13 in a patient with durvalumab-induced thyroiditis

Filette de , M.K Jeroen , Rop Jonas De , Stephanie Andre , Lynn De Mey , Sandrine Aspeslagh , Rafik Karmali , der Auwera Bart J Van , Bert Bravenboer

Background: Immune checkpoint inhibitors (ICI) targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death protein 1 and its ligand (PD-1/PD-L1) are the current standard-of-care for many advanced cancers (1). This novel therapeutic approach comes with its costs in the form of immune-related adverse events (irAE). The underlying mechanisms are not yet fully understood. We explore the role of HLA in endocrinopathy related to ICI therapy using an interes...

ea0081p165 | Pituitary and Neuroendocrinology | ECE2022

Effects of the SGLT2-inhibitor empagliflozin in patients with chronic syndrome of inadequate antidiuresis (SIAD) - results of a double-blind, randomized, placebo-controlled, crossover trial

Refardt Julie , Imber Cornelia , Nobbenhuis Rianne , Clara Odilia Sailer , Haslbauer Aaron , Vogt Deborah , Berres Manfred , Winzeler Bettina , Bridenbaugh Stephanie , Mirjam Christ-Crain

Introduction: Hyponatremia is the most common electrolyte disorder and the syndrome of inappropriate antidiuresis (SIAD) is one of its main causes. However, treatment options for chronic SIAD-induced hyponatremia are inadequate. This is problematic because hyponatremia has been associated with neurocognitive deficits, although there is little data on its reversibility. We previously showed that the sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin is a promising s...

ea0086p97 | Neuroendocrinology and Pituitary | SFEBES2022

Aberrant cyclic GMP-AMP synthase stimulator of interferon genes signalling in an AIP mutant cell line

Benjamin Loughrey Paul , Suleyman Oniz , Begalli Federica , Craig Stephanie G , Hunter Steven J , McArt Darragh G , James Jacqueline A , Haworth Oliver , Barry Sayka , Korbonits Marta

Background: The cyclic GMP-AMP synthase stimulator of interferon genes (cGAS-STING) signalling pathway is an element of the innate immune response and is activated by the presence of DNA in the cytosol. Triggering of this immune response may occur in the setting of infection or neoplasia. Activation of this pathway results in phosphorylation of interferon regulatory factor 3 and downstream transcription of cytokines such as interferon β and interleukin-6. Polyinosinic:pol...

ea0086p344 | Neuroendocrinology and Pituitary | SFEBES2022

CRN04894: an oral, nonpeptide adrenocorticotropic hormone (ACTH) receptor antagonist decreases basal and stimulated cortisol secretion in healthy volunteers

Trainer Peter , Ferrara-Cook Christine , Ayala Alejandro , Luo Rosa , Miller Stephanie , Wang Yang , Hernandez-Illas Martha , Scott Struthers R. , Betz Stephen , Krasner Alan

CRN04894 is a potent, orally bioavailable nonpeptide that is a highly selective antagonist for melanocortin type 2 receptor (MC2R). This receptor is found exclusively in the adrenal cortex and is the primary mediator of adrenal activation. We report results from a randomized, double-blinded, placebo-controlled (6 active:3 placebo/cohort), multiple ascending dose (40, 60, and 80 mg) study in health volunteers evaluating safety, pharmacokinetics, and pharmacodynamics of oral, on...

ea0090p293 | Adrenal and Cardiovascular Endocrinology | ECE2023

Modulation of calcium signaling ‘on demand‘ in adrenocortical cells to decipher the molecular mechanisms responsible for primary aldosteronism

Bakhta Fedlaoui , Teresa Cosentino , Sayed Zeina Al , Isabelle Giscos-Douriez , Jean-Sebastien Hulot , Fernandes-Rosa Fabio , Simon Travers , Stephanie Baron , Maria-Christina Zennaro , Boulkroun Sheerazed

Introduction: Primary aldosteronism (PA) is the most frequent form of secondary hypertension. Over the past 10 years, important discoveries have been made regarding the genetic basis of aldosterone producing adenoma and familial forms of primary aldosteronism. In most cases, genetic abnormalities are found in genes coding for ion channels (KCNJ5, CACNA1D, CACNA1H, CLCN2) and pumps (ATP1A1, ATP2B3). These mutations affect intracellular ion homeostasis and/or c...

ea0090ep705 | Pituitary and Neuroendocrinology | ECE2023

Pituitary macroadenoma apoplexy following treatment with pembrolizumab

Lopes Stephanie Andrade , Sciotto-Canel Lucie , Momjian Shahan , Aissa Assma Ben , Brocco Elise , Becquart Ondine , Egervari Kristof , Merkler Doron , Jornayvaz Francois , Leboulleux Sophie , Mavromati Maria

A 70-year old man was referred to the endocrinology department for the evaluation of a pituitary macroadenoma which was diagnosed during work-up for a malignant melanoma. Pituitary MRI showed a 20×21×25 mm adenoma with supra-sellar extension and no compression of the optic chiasma. Hormonal work-up revealed central hypogonadism and slight hyperprolactinemia due to stalk compression, while pituitary function was otherwise normal. MRI follow-up was scheduled in six mon...